Citation: K. Mahlberg et al., PREVENTION OF HIGH-RISK CORNEAL GRAFT-REJECTION USING CYCLOSPORINE-A (CSA) INCORPORATED INTO A COLLAGEN MATRIX, Ocular immunology and inflammation, 5(2), 1997, pp. 101-110
Citation: K. Mahlberg et al., COMPATIBILITY OF CORTICOSTEROIDS AND ANTIBIOTICS IN COMBINATION, Journal of cataract and refractive surgery, 23(6), 1997, pp. 878-882
Authors:
UUSITALO RJ
MAHLBERG K
KROOTILA K
RUUSUVAARA P
Citation: Rj. Uusitalo et al., SYSTEMIC CYCLOSPORINE TREATMENT FOR HIGH-RISK CORNEAL TRANSPLANTATION, Ocular immunology and inflammation, 4(1), 1996, pp. 15-24
Authors:
DUA HS
JINDAL VK
GOMES JAP
DONOSO LA
LAIBSON PR
MAHLBERG K
Citation: Hs. Dua et al., THE EFFECT OF TOPICAL CYCLOSPORINE ON CONJUNCTIVA ASSOCIATED LYMPHOID-TISSUE (CALT) OF RAT, Investigative ophthalmology & visual science, 36(4), 1995, pp. 1014-1014
Authors:
SINGH A
JINDAL VK
GOMES JAP
AHMAD NN
APPA SN
ARBIZO V
REYES P
MAHLBERG K
DONOSO LA
DUA HS
Citation: A. Singh et al., PREPARATION AND CHARACTERIZATION OF A MONOCLONAL-ANTIBODY THAT RECOGNIZES A UNIQUE EPITOPE IN RETINAL S-ANTIGEN, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1562-1562
Citation: K. Mahlberg et al., SELECTION OF CORTICOSTEROIDS AND ANTIBIOTICS FOR COLLAGEN SHIELDS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 776-776